The Patent Finder
US

Methods of Treating Chronic Inflammatory Disease with Secukinumab

US 12,551,554 In force
OverviewFamilyAssignmentsSources & methods

Term ends Oct 7, 2031 · Medium confidence

Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 10,583,190), so the cap could be lower.

Filed Dec 16, 2024 as application 18/983,030 · Granted Feb 17, 2026
Base term, 20 years from filing
Today
20 years from filing
2011 2031
Clock starts
Oct 7, 2011
Term ends
Oct 7, 2031
Granted
Feb 17, 2026
base term Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,434,172, US 10,583,190, US 11,278,618, US 11,351,253, US 11,534,490, US 9,717,791, to Oct 7, 2031. The term already ends on or before that date, so the cap shortened nothing.
0 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
10
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 1 maintenance fees are paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Oct 7, 2011, when application PCT/EP2011/067522, the earliest non-provisional in its chain, was filed (this one was filed Dec 16, 2024)Oct 7, 2031High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,434,172, US 10,583,190, US 11,278,618, US 11,351,253, US 11,534,490, US 9,717,791)resolves to Oct 7, 2031, no earlier than this term, so no changeMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 1 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderOct 7, 2031Medium confidence

This family

US 9,717,791In force
May 2032
May 2032
US 10,583,190In force
no later than Oct 2031
no later than Oct 2031
US 11,534,490In force
Oct 2031
Oct 2031
Application 17/127,738Abandoned
not computed
not computed
Application 17/165,724Abandoned
not computed
not computed
Application 18/061,227Pending
not computed
not computed
US 12,594,331In force
Oct 2031
Oct 2031
US 12,551,554this patent
Oct 2031
Oct 2031
8 of 10 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Feb 28, 2025
Reel 70369, frame 376
Guettner, Achim; Machacek, Matthias; Papavassilis, Charis; Sander, OliverNovartis AGAssignment of Assignor's Interest
Jun 11, 2026
Reel 75712, frame 291
Novartis AGNovartis Pharma AGAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited